From: Renal dysfunction and prognosis of COVID-19 patients: a hospital-based retrospective cohort study
Renal indexes | On admission (N=154) | Discharge (N=150) | ||||
---|---|---|---|---|---|---|
Median (P25, P75) | Below the range, N (%) | Above the range, N (%) | Median (P25, P75) | Below the range, N (%) | Above the range, N (%) | |
Uric acid (μmol/L) | 235.0 (183.0, 299.5) | 52 (33.8) | 4 (2.6) | 283.0 (237.0, 351.0) * | 43 (28.6) | 0# |
Urea nitrogen (mmol/L) | 3.7 (3.1, 4.7) | 35 (22.7) | 4 (2.6) | 3.9 (3.4, 4.8) | 17 (11.5) | 0# |
Creatinine (μmol/L) | 65.5 (52.0, 77.0) | 3 (1.9) | 1 (0.6) | 59.0 (48.0, 71.0) | 5 (3.4) | 1 (0.7) |
Cystatin C (mg/L) | 0.8 (0.7, 0.9) | 15 (9.7) | 6 (3.9) | 0.76 (0.69, 0.87) | 14 (9.5) | 2 (1.4) |
eGFR (mL/min) | 125.8 (103.0, 148.6) | 6 (3.9) | 86 (55.8) | 134.1 (118.7, 156.5) | 2 (1.4) | 72 (48.6) |
Renal dysfunction, N (%) | 16 (10.4%) | 5 (3.33%)† |